tiprankstipranks
Leonardo Drs, Inc. (DRS)
NASDAQ:DRS
US Market
Want to see DRS full AI Analyst Report?

Leonardo Drs (DRS) Earnings Dates, Call Summary & Reports

1,141 Followers

Earnings Data

Report Date
Aug 05, 2026
TBA (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
0.27
Last Year’s EPS
0.23
Same Quarter Last Year
Moderate Buy
Based on 7 Analysts Ratings

Earnings Call Summary

Q1 2026
Earnings Call Date:May 05, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call presented a strong financial quarter with clear operational momentum: revenue and profitability grew meaningfully (revenue +6%, adjusted EBITDA +28%, margin +210 bps), backlog hit record levels, and management raised full-year guidance across revenue, adjusted EBITDA and adjusted EPS. Positives from program execution, favorable material timing, contract wins (including a $533M DAIRCM IDIQ) and product innovation outweigh the main negatives—seasonal free cash outflow, short-term variability tied to timing of receipts and program execution, and budgetary uncertainty from Congress. Management is investing to capture demand, which pressures near-term cash conversion but supports growth and margin expansion.
Company Guidance
The company raised full‑year 2026 guidance to revenue of $3.900–$3.975 billion (implying ~7%–9% organic growth) and adjusted EBITDA of $515–$530 million, with adjusted diluted EPS now guided to $1.26–$1.30 (tax rate assumption 18.5% and diluted share count 269 million); management also targets free cash flow of roughly 75% of adjusted net earnings and expects capex to ramp to about 5% of sales for the year. This follows a strong Q1: revenue $846 million (+6% YoY), adjusted EBITDA $105 million (+28% YoY) with a 12.4% margin (+210 bps), net earnings $62 million (diluted EPS $0.23) and adjusted net earnings $69 million (adjusted diluted EPS $0.26). Segment performance included ASC adjusted EBITDA up 48% (+290 bps margin expansion) and IMS adjusted EBITDA up 8% (IMS margin ~14.6%, +90 bps); funded backlog hit company records and book‑to‑bill remained ≥1x for the 17th consecutive quarter. For Q2 management expects revenue around $900 million, adjusted EBITDA margin in the mid‑12% range and to be modestly free‑cash‑flow positive; the full‑year guide assumes improved margins, lower net interest expense and slightly higher working capital investment to fund growth.
Revenue Growth
Q1 revenue of $846 million, up 6% year-over-year, driven by tactical radars, infrared sensing and electric power & propulsion.
Strong Profitability Expansion
Adjusted EBITDA of $105 million, up 28% year-over-year; adjusted EBITDA margin of 12.4%, expanding 210 basis points year-over-year.
Improved Bottom-Line Results
Net earnings of $62 million (up 24% YoY) and diluted EPS of $0.23 (up 21% YoY). Adjusted net earnings of $69 million (up 28% YoY) and adjusted diluted EPS of $0.26 (up 30% YoY).
Record Backlog and Book-to-Bill Momentum
17th consecutive quarter with book-to-bill of at least 1x, with funded backlog reaching new company records, enhancing revenue visibility for the year.
Raised Full-Year Guidance
Full-year revenue guidance raised to $3.9B–$3.975B, implying organic growth of 7%–9%; adjusted EBITDA guidance raised to $515M–$530M; adjusted diluted EPS guidance raised to $1.26–$1.30 per share.
Segment Performance: ASC and IMS
ASC adjusted EBITDA increased 48% YoY with margin expansion of 290 basis points, reflecting tactical radar and sensing strength. IMS adjusted EBITDA increased 8% YoY with margin expansion of 90 basis points, driven in large part by Columbia Class execution.
Material and Mix Tailwinds
Favorable material receipt timing and improved raw material results (including germanium) contributed to revenue acceleration and margin expansion in Q1.
Significant Contract Wins & Product Innovation
Received a $533 million DAIRCM production contract IDIQ; launched THOR tactical high-performance embedded computing product and demonstrated counter-UAS capabilities on unmanned ground and surface vessels; investments in open architectures (SAGEcore) and next-gen sensing.

Leonardo Drs (DRS) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

DRS Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 05, 2026
2026 (Q2)
0.27 / -
0.23
May 05, 2026
2026 (Q1)
0.20 / 0.26
0.230.00% (+0.06)
Feb 24, 2026
2025 (Q4)
0.37 / 0.42
0.3810.53% (+0.04)
Oct 29, 2025
2025 (Q3)
0.28 / 0.29
0.2420.83% (+0.05)
Jul 30, 2025
2025 (Q2)
0.21 / 0.23
0.1827.78% (+0.05)
May 01, 2025
2025 (Q1)
0.17 / 0.20
0.1442.86% (+0.06)
Feb 20, 2025
2024 (Q4)
0.35 / 0.38
0.3122.58% (+0.07)
Oct 30, 2024
2024 (Q3)
0.20 / 0.24
0.220.00% (+0.04)
Jul 30, 2024
2024 (Q2)
0.14 / 0.18
0.1520.00% (+0.03)
May 01, 2024
2024 (Q1)
0.12 / 0.14
0.07100.00% (+0.07)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

DRS Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 05, 2026
$40.00$39.70-0.75%
Feb 24, 2026
$38.07$43.74+14.89%
Oct 29, 2025
$40.00$38.26-4.36%
Jul 30, 2025
$47.88$42.95-10.29%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Leonardo Drs, Inc. (DRS) report earnings?
Leonardo Drs, Inc. (DRS) is schdueled to report earning on Aug 05, 2026, TBA (Confirmed).
    What is Leonardo Drs, Inc. (DRS) earnings time?
    Leonardo Drs, Inc. (DRS) earnings time is at Aug 05, 2026, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is DRS EPS forecast?
          DRS EPS forecast for the fiscal quarter 2026 (Q2) is 0.27.